|
|
Volumn 10, Issue 1, 2011, Pages 5-6
|
|
Suspense builds on anti-obesity rollercoaster ride
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
ANTIDIABETIC AGENT;
GLUCAGON LIKE PEPTIDE;
LIRAGLUTIDE;
LORCASERIN;
METRELEPTIN;
NALTREXONE;
PHENTERMINE;
PLACEBO;
PRAMLINTIDE;
SIBUTRAMINE;
TESOFENSINE;
TOPIRAMATE;
UNCLASSIFIED DRUG;
ZONISAMIDE;
ADIPOSE TISSUE;
ARTICLE;
BIOTECHNOLOGY;
DECREASED APPETITE;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG SAFETY;
EUROPEAN UNION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LIPID METABOLISM;
OBESITY;
PRIORITY JOURNAL;
SATIETY;
UNITED STATES;
WEIGHT CONTROL;
ANTI-OBESITY AGENTS;
DRUG APPROVAL;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
OBESITY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 78650847815
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3353 Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
